2025 HCPCS Code C9166
Injection, secukinumab, intravenous, 1 mg
Notice | HCPCS C9166 terminated on June 30, 2024. |
Short Description | Injection, secukinumab |
HCPCS Action Code | D - Discontinue procedure or modifier code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | April 01, 2024 |
HCPCS Action Effective Date | July 01, 2024 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C8929 - Tte w or wo fol wcon,doppler
- C8930 - Tte w or w/o contr, cont ecg
- C8931 - Mra, w/dye, spinal canal
- C8932 - Mra, w/o dye, spinal canal
- C8933 - Mra, w/o&w/dye, spinal canal
- C8934 - Mra, w/dye, upper extremity
- C8935 - Mra, w/o dye, upper extr
- C8936 - Mra, w/o&w/dye, upper extr
- C8937 - Cad breast mri
- C8957 - Prolonged iv inf, req pump
- C9014 - Injection, cerliponase alfa
- C9015 - C-1 esterase, haegarda
- C9016 - Inj, triptorelin ext rel
- C9021 - Injection, obinutuzumab
- C9022 - Injection, elosulfase alfa
- C9023 - Inj testosterone undecanoate
- C9024 - Inj, daunorubicin-cytarabine
- C9025 - Injection, ramucirumab
- C9026 - Injection, vedolizumab
- C9027 - Injection, pembrolizumab